Product Information

MYCOPHENOLIC ACID DR 180 MG TB is a generic product labeled by Biocon Pharma Inc., priced at $0.1045 per EA under NDC 70377012611. Its NADAC has been published 93 times since Feb 12, 2025.

FDA first approved this application on Nov 29, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MYCOPHENOLIC ACID DR 180 MG TB

Mycophenolic Acid
$0.1045per EA

Strength

180 mg/1

Manufacturer

Biocon Pharma Inc.

NDC

70377012611

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MYCOPHENOLATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA217031

FDA Approved

11/29/2023

TE Code

AB

On Market Since

9/30/2024

Pharmacological Classes

Price Statistics

The NADAC for MYCOPHENOLIC ACID DR 180 MG TB has been published 93 times since Feb 12, 2025, and over the history we have for it it has declined 28.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1045 per EA
All-time high$0.1669 (May 14, 2025)
All-time low$0.0985 (Aug 19, 2026)
52-week high$0.1404
52-week low$0.0985
Median price$0.1394
Average price$0.1352
Largest weekly change+8.3% (Feb 19, 2025)
Weeks tracked93
Tracking sinceFeb 12, 2025

Price History

1W

+2.2%

1M

+5.0%

3M

+6.1%

6M

-11.0%

1Y

-25.0%

3Y

N/A

5Y

N/A

All

-28.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MYCOPHENOLIC ACID DR 180 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLIC ACID DR 180 MG TB, manufactured by Biocon Pharma Inc., is $0.1045 per EA (NDC 70377012611), effective Nov 18, 2026.

How has the price of MYCOPHENOLIC ACID DR 180 MG TB changed over time?

Over the history we have for it, the NADAC for MYCOPHENOLIC ACID DR 180 MG TB has declined 28.5%. It has been tracked across 93 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for MYCOPHENOLIC ACID DR 180 MG TB?

Since Feb 12, 2025, the NADAC for MYCOPHENOLIC ACID DR 180 MG TB has ranged from a low of $0.0985 (Aug 19, 2026) to a high of $0.1669 (May 14, 2025), with a median of $0.1394 per EA.

Are there cheaper alternatives to MYCOPHENOLIC ACID DR 180 MG TB?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MYCOPHENOLIC ACID DR 180 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures MYCOPHENOLIC ACID DR 180 MG TB?

MYCOPHENOLIC ACID DR 180 MG TB (NDC 70377012611) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.